...
search icon
nrxp-img

NRX Pharmaceuticals Inc Share Price

NRXP
NAQ
$1.84
+$0.07
(3.94%)
1D
Industry: Biotechnology Sector: Health Care

NRX Pharmaceuticals Inc Analyst Forecast

NRX Pharmaceuticals Inc Share Price Chart

NRX Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$52.55M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
680.51K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.96
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.58 L
$3.84 H
$1.84

About NRX Pharmaceuticals Inc, Common Stock

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital; and has as a partnership with neurocare Group AG to create a nationwide network of clinics to offer integrated neuroplastic care for the treatment of Depression, PTSD, and other serious mental health disorders. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware. more

Industry: BiotechnologySector: Health Care

NRX Pharmaceuticals Inc Stock Returns

Time FrameNRXPSectorS&P500
1-Week Return6.36%1.07%0.74%
1-Month Return-15.6%1.46%1.28%
3-Month Return-13.62%3.51%3.6%
6-Month Return-26.55%15.29%7.31%
1-Year Return-27.56%7.7%11.97%
3-Year Return-83.12%21.02%72.07%
5-Year Return-99.53%37.81%76.01%
10-Year Return-98.08%139.15%258.47%

NRX Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue2.00K2.00K4.00K5.00K5.00K[{"date":"2020-12-31","value":40,"profit":true},{"date":"2021-12-31","value":40,"profit":true},{"date":"2022-12-31","value":80,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(2.00K)(2.00K)(4.00K)(5.00K)(5.00K)[{"date":"2020-12-31","value":-200000,"profit":false},{"date":"2021-12-31","value":-200000,"profit":false},{"date":"2022-12-31","value":-400000,"profit":false},{"date":"2023-12-31","value":-500000,"profit":false},{"date":"2024-12-31","value":-500000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses22.06M95.20M44.33M27.58M19.70M[{"date":"2020-12-31","value":23.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":46.57,"profit":true},{"date":"2023-12-31","value":28.97,"profit":true},{"date":"2024-12-31","value":20.69,"profit":true}]
Operating Income(22.06M)(95.20M)(44.34M)(27.59M)(19.70M)[{"date":"2020-12-31","value":-2206100000,"profit":false},{"date":"2021-12-31","value":-9520100000,"profit":false},{"date":"2022-12-31","value":-4433500000,"profit":false},{"date":"2023-12-31","value":-2758700000,"profit":false},{"date":"2024-12-31","value":-1970400000,"profit":false}]
Total Non-Operating Income/Expense(29.77M)2.12M4.83M(2.05M)(5.61M)[{"date":"2020-12-31","value":-616.4,"profit":false},{"date":"2021-12-31","value":43.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-42.44,"profit":false},{"date":"2024-12-31","value":-116.11,"profit":false}]
Pre-Tax Income(51.78M)(93.06M)(39.75M)(30.15M)(25.13M)[{"date":"2020-12-31","value":-5177700000,"profit":false},{"date":"2021-12-31","value":-9306300000,"profit":false},{"date":"2022-12-31","value":-3975400000,"profit":false},{"date":"2023-12-31","value":-3015000000,"profit":false},{"date":"2024-12-31","value":-2512600000,"profit":false}]
Income Taxes(39.43M)(21.35M)(4.58M)(9.00K)-[{"date":"2020-12-31","value":-3943000000,"profit":false},{"date":"2021-12-31","value":-2134800000,"profit":false},{"date":"2022-12-31","value":-458100000,"profit":false},{"date":"2023-12-31","value":-900000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(12.35M)(71.72M)(35.17M)(30.14M)-[{"date":"2020-12-31","value":-1234700000,"profit":false},{"date":"2021-12-31","value":-7171500000,"profit":false},{"date":"2022-12-31","value":-3517300000,"profit":false},{"date":"2023-12-31","value":-3014100000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(1.09M)(93.06M)(39.75M)(36.06M)(25.13M)[{"date":"2020-12-31","value":-108951000,"profit":false},{"date":"2021-12-31","value":-9306300000,"profit":false},{"date":"2022-12-31","value":-3975400000,"profit":false},{"date":"2023-12-31","value":-3605900000,"profit":false},{"date":"2024-12-31","value":-2512600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(51.78M)(93.06M)(39.75M)(30.15M)(25.13M)[{"date":"2020-12-31","value":-5177700000,"profit":false},{"date":"2021-12-31","value":-9306300000,"profit":false},{"date":"2022-12-31","value":-3975400000,"profit":false},{"date":"2023-12-31","value":-3015000000,"profit":false},{"date":"2024-12-31","value":-2512600000,"profit":false}]
EPS (Diluted)(2.27)(7.60)(0.62)(0.85)(2.33)[{"date":"2020-12-31","value":-226.88,"profit":false},{"date":"2021-12-31","value":-760,"profit":false},{"date":"2022-12-31","value":-62,"profit":false},{"date":"2023-12-31","value":-85,"profit":false},{"date":"2024-12-31","value":-233,"profit":false}]

NRX Pharmaceuticals Inc Ratios

NRX Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NRXP
Cash Ratio 0.18
Current Ratio 0.29

NRX Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NRXP
ROA (LTM) -97.83%
ROE (LTM) -682.61%

NRX Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NRXP
Debt Ratio Lower is generally better. Negative is bad. 2.72
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.72

NRX Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NRXP
Trailing PE NM
Forward PE 7.20
P/S (TTM) 217.15
P/B 2.90
Price/FCF NM
EV/R 233.53
EV/Ebitda NM

FAQs

What is NRX Pharmaceuticals Inc share price today?

NRX Pharmaceuticals Inc (NRXP) share price today is $1.84

Can Indians buy NRX Pharmaceuticals Inc shares?

Yes, Indians can buy shares of NRX Pharmaceuticals Inc (NRXP) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NRXP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NRX Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of NRX Pharmaceuticals Inc (NRXP) via the Vested app. You can start investing in NRX Pharmaceuticals Inc (NRXP) with a minimum investment of $1.

How to invest in NRX Pharmaceuticals Inc shares from India?

You can invest in shares of NRX Pharmaceuticals Inc (NRXP) via Vested in three simple steps:

  • Click on Sign Up or Invest in NRXP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NRX Pharmaceuticals Inc shares
What is NRX Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of NRX Pharmaceuticals Inc (NRXP) is $3.84. The 52-week low price of NRX Pharmaceuticals Inc (NRXP) is $1.58.

What is NRX Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NRX Pharmaceuticals Inc (NRXP) is

What is NRX Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NRX Pharmaceuticals Inc (NRXP) is 2.90

What is NRX Pharmaceuticals Inc dividend yield?

The dividend yield of NRX Pharmaceuticals Inc (NRXP) is 0.00%

What is the Market Cap of NRX Pharmaceuticals Inc?

The market capitalization of NRX Pharmaceuticals Inc (NRXP) is $52.55M

What is NRX Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of NRX Pharmaceuticals Inc is NRXP

How Can Investors Use NRX Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of NRX Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether NRX Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from NRX Pharmaceuticals Inc shares for Indian investors?

When investing in NRX Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the NRX Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare NRX Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of NRX Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that NRX Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top